JAK2 and diabetic kidney disease: Furthermore, administration of JAK2 inhibitors, including baricitinib and Huang Gan formula, effectively improves kidney function in CKD and DKD, which indicates that JAK2 inhibitors might be useful as new therapies for CKD and DKD38,39.